Investing.com -- Wedbush analysts expect tech stocks to end the year on a positive note with a “Santa rally,” citing positive catalysts including deregulation under Donald Trump’s second term and ...
Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...
Tesla’s strategic pivot toward AI and autonomy reinforces its position as a leading disruptive technology company, not merely an automaker, the analysts said. Investors are closely watching regulatory ...